Treatment Outcomes in Multidrug-Resistant Tuberculosis.
Research Center Borstel, Borstel, Germany clange@fz-borstel.de.
Gunar
G
Günther
Research Center Borstel, Borstel, Germany clange@fz-borstel.de.
Christoph
C
Lange
Institute of Phtisiopneumology, Chisinau, Moldova.
Sofia
S
Alexandru
Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Neus
N
Altet
Asklepios Klinik Gauting, Gauting, Germany.
Korkut
K
Avsar
Statens Serum Institut, Copenhagen, Denmark.
Didi
D
Bang
Balti Municipal Hospital, Balti, Moldova.
Raisa
R
Barbuta
Homerton University Hospital, London, United Kingdom.
Graham
G
Bothamley
Institute of Phtisiopneumology, Chisinau, Moldova.
Ana
A
Ciobanu
Institute of Phtisiopneumology, Chisinau, Moldova.
Valeriu
V
Crudu
Tartu University Lung Hospital, Tartu, Estonia.
Manfred
M
Danilovits
Heart of England Foundation Trust, Birmingham, United Kingdom.
Martin
M
Dedicoat
Porto University, Porto, Portugal.
Raquel
R
Duarte
Lazzaro Spallanzani National Institute for Infectious Diseases, Rome, Italy.
Gina
G
Gualano
Queen Mary University Hospital, London, United Kingdom.
Heinke
H
Kunst
University Medical Center Groningen, Groningen, the Netherlands.
Wiel
W
de Lange
Riga East University Hospital, Riga, Latvia.
Vaira
V
Leimane
Radboud University Medical Center, Nijmegen, the Netherlands.
Cecile
C
Magis-Escurra
St. James's Hospital, Dublin, Ireland.
Anne-Marie
AM
McLaughlin
University Medical Center St. Pieter, Brussels, Belgium.
Inge
I
Muylle
Thomayer University Hospital, Prague, Czech Republic.
Veronika
V
Polcová
Marius-Nasta-Institut, Bucharest, Romania.
Christina
C
Popa
Otto Wagner Hospital, Vienna, Austria.
Rudolf
R
Rumetshofer
Republican Research and Practical Center for Pulmonology and Tuberculosis, Minsk, Belarus.
Alena
A
Skrahina
Republican Research and Practical Center for Pulmonology and Tuberculosis, Minsk, Belarus.
Varvara
V
Solodovnikova
Marius-Nasta-Institut, Bucharest, Romania.
Victor
V
Spinu
Barts Health NHS Trust, London, United Kingdom.
Simon
S
Tiberi
National Institute for Health Development, Tallinn, Estonia.
Piret
P
Viiklepp
Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.
Frank
F
van Leth
D006801:Humans; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D017063:Outcome Assessment, Health Care / Q000379:methods*; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy; D014944:World Health Organization